Cargando…
合并MET基因变异的非小细胞肺癌治疗研究进展
Mesenchymal-epithelial transition factor (MET) has long been considered as the most crucial and promising driver gene in the occurrence and development of non-small cell lung cancer (NSCLC), except for epidermal growth factor receptor (EGFR), anaplastic lymphoma kinase (ALK), and c-ROS oncogene 1 re...
| Formato: | Online Artículo Texto |
|---|---|
| Lenguaje: | English |
| Publicado: |
中国肺癌杂志编辑部
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9845091/ https://www.ncbi.nlm.nih.gov/pubmed/36617474 http://dx.doi.org/10.3779/j.issn.1009-3419.2022.101.54 |